Description
Indenza – 160 mg
Composition: Enzalutamide 160mg
Therapeutic Class: Androgen Receptor Inhibitor
Indenza: Trusted Prostate Cancer Medicine
Indenza is widely accepted and prescribed by oncologists for the treatment of advanced, metastatic prostate cancers.
Aprazer: Advancing Anticancer Treatments
Aprazer, as the leading oncology medicine manufacturer, develops advanced anticancer medicines that are highly affordable and available across the globe.
WHO-GMP certified, assured therapeutic efficacy and safety. Available in 50+ countries.
What is Indenza?
Indenza is a second-generation drug that blocks androgen receptors, inhibiting testosterone-induced tumor growth.
Uses of Indenza
- • Castration Resistant Prostate Cancer
- • Advanced Stage Castration Resistant Prostate Cancer
- • Hormone-sensitive Castration Resistant Prostate Cancer
How does Indenza work?
It blocks testosterone receptors at multiple locations, the testes, CNS and androgen-sensitive tissues.
It stops the binding of testosterone to its receptors, thus it is effective even in the presence of low testosterone levels.
Shrink tumor growth and proliferation.
Common Side Effects
- • Dizziness
- • Fatigue
- • Muscle pain
- • Joint pain
- • Diarrhea
- • Skin rashes
- • Dryness
- • Hot flushes
Serious Side Effects
Generally, dose-dependent side effects are seen
- • Elevated liver enzymes
- • Neurological issues – seizures, confusion
- • High blood pressure
- • Reduced bone density
Contraindications
Not to be used if any previous allergy or hypersensitivity to Enzalutamide or any excipients.
- • Not prescribed for women
- • Breastfeeding mothers
- • Pregnant women
Precautions
Cautiously to be used in patients with:
- • Hypertensive patients
- • Neurological dysfunctions
- • Elderly and osteoarthritis patients
- • Cardiovascular dysfunctions
Warning
To be used under medical prescription only:
Important Safety and Monitoring Information
Regular monitoring of the liver function, cardiac function, bone density, and mineral levels.
